{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:19:02Z","timestamp":1784557142736,"version":"3.55.0"},"reference-count":53,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["etj.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,19]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intake of potassium iodide (KI) reduces the accumulation of radioactive iodine in the thyroid gland in the event of possible contamination by radioactive iodine released from a nuclear facility. The World Health Organization (WHO) has stated the need for research for optimal timing, appropriate dosing regimen, and safety for repetitive iodine thyroid blocking (ITB). The French PRIODAC project, addressed all these issues, involving prolonged or repeated releases of radioactive iodine. Preclinical studies established an effective dose through pharmacokinetic modeling, demonstrating the safety of repetitive KI treatment without toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Recent preclinical studies have determined an optimal effective dose for repetitive administration, associated with pharmacokinetic modeling. The results show the safety and absence of toxicity of repetitive treatment with KI. Good laboratory practice level preclinical studies corresponding to individuals &gt;12 years have shown a safety margin established between animal doses without toxic effect. After approval from the French health authorities, the market authorization of the two tablets of KI, 65 mg\/day, was defined with a new dosing scheme of a daily repetitive intake of the treatment up to 7 days unless otherwise instructed by the competent authorities for all categories of population except pregnant women and children under the age of 12 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This new marketed authorization resulting from scientific-based evidence obtained as part of the PRIODAC project may serve as an example to further harmonize the application of KI for repetitive ITB in situations of prolonged radioactive release at the European and international levels, under the umbrella of the WHO\n                      <jats:italic>.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-23-0139","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T12:41:49Z","timestamp":1705668109000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-16","source":"Crossref","is-referenced-by-count":2,"title":["Review of the PRIODAC project on thyroid protection from radioactive iodine by repeated iodide intake in individuals aged 12+"],"prefix":"10.1530","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2870-0012","authenticated-orcid":true,"given":"Jean-Charles","family":"Martin","sequence":"first","affiliation":[{"name":"Centre de recherche en CardioVasculaire et Nutrition (C2VN), Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE), Institut National pour la Sant\u00e9 Et la Recherche M\u00e9dicale (INSERM), Aix Marseille Universit\u00e9 (AMU), Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Pourcher","sequence":"additional","affiliation":[{"name":"Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat \u00e0 l\u2019Energie Atomique et aux Energies alternatives (CEA), Universit\u00e9 C\u00f4te d\u2019Azur (UCA), School of Medicine, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Phan","sequence":"additional","affiliation":[{"name":"Institut de Radioprotection et de S\u00fbret\u00e9 Nucl\u00e9aire (IRSN), PSE-Sant\u00e9, Fontenay-aux-Roses, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Guglielmi","sequence":"additional","affiliation":[{"name":"Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat \u00e0 l\u2019Energie Atomique et aux Energies alternatives (CEA), Universit\u00e9 C\u00f4te d\u2019Azur (UCA), School of Medicine, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Crambes","sequence":"additional","affiliation":[{"name":"Pharmacie Centrale des Arm\u00e9es (PCA), Direction des Approvisionnements en produits de Sant\u00e9 des Arm\u00e9es, Fleury-les-Aubrais, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Caire-Maurisier","sequence":"additional","affiliation":[{"name":"Pharmacie Centrale des Arm\u00e9es (PCA), Direction des Approvisionnements en produits de Sant\u00e9 des Arm\u00e9es, Fleury-les-Aubrais, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalila","family":"Lebsir","sequence":"additional","affiliation":[{"name":"Institut de Radioprotection et de S\u00fbret\u00e9 Nucl\u00e9aire (IRSN), PSE-Sant\u00e9, Fontenay-aux-Roses, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cohen","sequence":"additional","affiliation":[{"name":"Institut de Radioprotection et de S\u00fbret\u00e9 Nucl\u00e9aire (IRSN), PSE-Sant\u00e9, Fontenay-aux-Roses, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Rosique","sequence":"additional","affiliation":[{"name":"Centre de recherche en CardioVasculaire et Nutrition (C2VN), Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE), Institut National pour la Sant\u00e9 Et la Recherche M\u00e9dicale (INSERM), Aix Marseille Universit\u00e9 (AMU), Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6397-0627","authenticated-orcid":true,"given":"Lun","family":"Jing","sequence":"additional","affiliation":[{"name":"Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat \u00e0 l\u2019Energie Atomique et aux Energies alternatives (CEA), Universit\u00e9 C\u00f4te d\u2019Azur (UCA), School of Medicine, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Hichri","sequence":"additional","affiliation":[{"name":"Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat \u00e0 l\u2019Energie Atomique et aux Energies alternatives (CEA), Universit\u00e9 C\u00f4te d\u2019Azur (UCA), School of Medicine, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Salleron","sequence":"additional","affiliation":[{"name":"Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat \u00e0 l\u2019Energie Atomique et aux Energies alternatives (CEA), Universit\u00e9 C\u00f4te d\u2019Azur (UCA), School of Medicine, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Darcourt","sequence":"additional","affiliation":[{"name":"Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat \u00e0 l\u2019Energie Atomique et aux Energies alternatives (CEA), Universit\u00e9 C\u00f4te d\u2019Azur (UCA), School of Medicine, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maamar","family":"Souidi","sequence":"additional","affiliation":[{"name":"Institut de Radioprotection et de S\u00fbret\u00e9 Nucl\u00e9aire (IRSN), PSE-Sant\u00e9, Fontenay-aux-Roses, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Benderitter","sequence":"additional","affiliation":[{"name":"Institut de Radioprotection et de S\u00fbret\u00e9 Nucl\u00e9aire (IRSN), PSE-Sant\u00e9, Fontenay-aux-Roses, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Radiation Protection Dosimetry","first-page":"67","article-title":"Multiple administrations of stable iodide protect population chronically exposed to radioactive iodine: what is priodac research program (2014-22) teaching us?","volume":"182","author":"Benderitter","year":"2018","unstructured":"Benderitter MPourcher TMartin J-CDarcourt JGuigon PCaire-Maurisier FPech ALebsir DRosique C & Guglielmi J. Multiple administrations of stable iodide protect population chronically exposed to radioactive iodine: what is priodac research program (2014-22) teaching us?Radiation Protection Dosimetry201818267\u201379. (https:\/\/doi.org\/10.1093\/rpd\/ncy129)"},{"key":"bib2","series-title":"Endocrine Reviews","first-page":"1","article-title":"Radiation-related thyroid cancer","volume":"45","author":"Saenko","year":"2024","unstructured":"Saenko V & Mitsutake N. Radiation-related thyroid cancer. Endocrine Reviews2024451\u201329. (https:\/\/doi.org\/10.1210\/endrev\/bnad022)"},{"key":"bib3","series-title":"Protection of the Human E. Guidelines for Iodine Prophylaxis Following Nuclear Accidents: Update 1999","year":"1999","unstructured":"World Health OrganizationProtection of the Human E. Guidelines for Iodine Prophylaxis Following Nuclear Accidents: Update 1999. Geneva: World Health Organization1999."},{"key":"bib4","series-title":"Thyroid","first-page":"607","article-title":"Protecting the thyroid in times of conflict (Ukraine 2022)","volume":"32","author":"Toft","year":"2022","unstructured":"Toft DJ & Schneider AB. Protecting the thyroid in times of conflict (Ukraine 2022). Thyroid202232607\u2013610. (https:\/\/doi.org\/10.1089\/thy.2022.0135)"},{"key":"bib5","series-title":"Biochimie","first-page":"1793","article-title":"From the molecular characterization of iodide transporters to the prevention of radioactive iodide exposure","volume":"88","author":"Dayem","year":"2006","unstructured":"Dayem MNavarro VMarsault RDarcourt JLindenthal S & Pourcher T. From the molecular characterization of iodide transporters to the prevention of radioactive iodide exposure. Biochimie2006881793\u20131806. (https:\/\/doi.org\/10.1016\/j.biochi.2006.07.015)"},{"key":"bib6","series-title":"Molecular Endocrinology","first-page":"1924","article-title":"Regulation of thyroid oxidative state by thioredoxin reductase has a crucial role in thyroid responses to iodide excess","volume":"25","author":"Leoni","year":"2011","unstructured":"Leoni SGKimura ETSantisteban P & De la Vieja A. Regulation of thyroid oxidative state by thioredoxin reductase has a crucial role in thyroid responses to iodide excess. Molecular Endocrinology2011251924\u20131935. (https:\/\/doi.org\/10.1210\/me.2011-0038)"},{"key":"bib7","series-title":"Thyroid","first-page":"353","article-title":"Iodine kinetics and effectiveness of stable iodine prophylaxis after intake of radioactive iodine: a review","volume":"11","author":"Verger","year":"2001","unstructured":"Verger PAurengo AGeoffroy B & Le Guen B. Iodine kinetics and effectiveness of stable iodine prophylaxis after intake of radioactive iodine: a review. Thyroid200111353\u2013360. (https:\/\/doi.org\/10.1089\/10507250152039082)"},{"key":"bib8","series-title":"Protection","year":"2017","unstructured":"World Health Organization. Protection of the Human E, Radiation and health Team. Iodine thyroid blocking: guidelines for use in planning and responding to radiological and nuclear emergencies. Geneva: World Health Organization2017."},{"key":"bib9","series-title":"JAMA","first-page":"1036","article-title":"Reduction of thyroid irradiation from 131-I by potassium iodide","volume":"200","author":"Blum","year":"1967","unstructured":"Blum M & Eisenbud M. Reduction of thyroid irradiation from 131-I by potassium iodide. JAMA19672001036\u20131040. (https:\/\/doi.org\/10.1001\/jama.1967.03120250070012)"},{"key":"bib10","series-title":"New England Journal of Medicine","first-page":"1083","article-title":"Suppression of thyroid radioiodine uptake by various doses of stable iodide","volume":"303","author":"Sternthal","year":"1980","unstructured":"Sternthal ELipworth LStanley BAbreau CFang SL & Braverman LE. Suppression of thyroid radioiodine uptake by various doses of stable iodide. New England Journal of Medicine19803031083\u20131088. (https:\/\/doi.org\/10.1056\/NEJM198011063031903)"},{"key":"bib11","series-title":"Dose-Response","first-page":"1559325817746558","article-title":"Optimal KI Prophylactic Dose Determination for Thyroid Radiation Protection After a Single Administration in Adult Rats","volume":"15","author":"Phan","year":"2017","unstructured":"Phan GRebi\u00e8re FSuhard DLegrand ACarpentier FSontag TSouidi MJourdain JRAgarande M & Renaud-Salis V. Optimal KI Prophylactic Dose Determination for Thyroid Radiation Protection After a Single Administration in Adult Rats. Dose-Response2017151559325817746558. (https:\/\/doi.org\/10.1177\/1559325817746558)"},{"key":"bib12","series-title":"Pharmaceutical Research","first-page":"227","article-title":"Repeated KI prophylaxis in case of prolonged exposure to iodine radioisotopes: pharmacokinetic studies in adult rats","volume":"35","author":"Phan","year":"2018","unstructured":"Phan GChioukh RSuhard DLegrand AMoulin CSontag TRebi\u00e8re FBouvier-Capely CAgarande MRenaud-Salis V, et al.Repeated KI prophylaxis in case of prolonged exposure to iodine radioisotopes: pharmacokinetic studies in adult rats. Pharmaceutical Research201835227. (https:\/\/doi.org\/10.1007\/s11095-018-2515-1)"},{"key":"bib13","series-title":"bioRxiv","article-title":"New","author":"Guglielmi","year":"2023","unstructured":"Guglielmi JD\u2019Andr\u00e9a GCambien BGraslin FChatti KRobart ESchiazza AZwarthoed CHumbert OLindenthal S, et al.New insights into iodide metabolism based on preclinical models: impact on radiotherapy efficacy and protection against radioactive iodine exposure. bioRxiv2023. (https:\/\/doi.org\/10.1101\/2023.10.11.561684)"},{"key":"bib14","series-title":"International Journal of Pediatric Endocrinology","first-page":"8","article-title":"Iodide transport: implications for health and disease","volume":"2014","author":"Pesce","year":"2014","unstructured":"Pesce L & Kopp P. Iodide transport: implications for health and disease. International Journal of Pediatric Endocrinology201420148. (https:\/\/doi.org\/10.1186\/1687-9856-2014-8)"},{"key":"bib15","series-title":"Endocrine Reviews","first-page":"106","article-title":"The Na+\/I- symporter (NIS): mechanism and medical impact","volume":"35","author":"Portulano","year":"2014","unstructured":"Portulano CParoder-Belenitsky M & Carrasco N. The Na+\/I- symporter (NIS): mechanism and medical impact. Endocrine Reviews201435106\u2013149. (https:\/\/doi.org\/10.1210\/er.2012-1036)"},{"key":"bib16","series-title":"Endocrinology","first-page":"3404","article-title":"Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium\/iodide symporter messenger ribonucleic acid and protein","volume":"140","author":"Eng","year":"1999","unstructured":"Eng PHCardona GRFang SLPreviti MAlex SCarrasco NChin WW & Braverman LE. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium\/iodide symporter messenger ribonucleic acid and protein. Endocrinology19991403404\u20133410. (https:\/\/doi.org\/10.1210\/endo.140.8.6893)"},{"key":"bib17","series-title":"Molecular Endocrinology","first-page":"1183","article-title":"G\u03b2\u03b3 dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells","volume":"22","author":"Zaballos","year":"2008","unstructured":"Zaballos MAGarcia B & Santisteban P. G\u03b2\u03b3 dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells. Molecular Endocrinology2008221183\u20131199. (https:\/\/doi.org\/10.1210\/me.2007-0093)"},{"key":"bib18","series-title":"Journal of Endocrinology","first-page":"283","article-title":"Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease","volume":"209","author":"Maia","year":"2011","unstructured":"Maia ALGoemann IMMeyer EL & Wajner SM. Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease. Journal of Endocrinology2011209283\u2013297. (https:\/\/doi.org\/10.1530\/JOE-10-0481)"},{"key":"bib19","series-title":"Hormone and Metabolic Research","first-page":"910","article-title":"MCT8 is Downregulated by Short Time Iodine Overload in the Thyroid Gland of Rats","volume":"47","author":"de Souza","year":"2015","unstructured":"de Souza ECDias GRCardoso RCLima LPFortunato RSVisser TJVaisman MFerreira AC & Carvalho DP. MCT8 is Downregulated by Short Time Iodine Overload in the Thyroid Gland of Rats. Hormone and Metabolic Research201547910\u2013915. (https:\/\/doi.org\/10.1055\/s-0035-1550008)"},{"key":"bib20","series-title":"Molecular and Cellular Endocrinology","first-page":"119","article-title":"Effects of repeated potassium iodide administration on genes involved in synthesis and secretion of thyroid hormone in adult male rat","volume":"474","author":"Lebsir","year":"2018","unstructured":"Lebsir DManens LGrison SLestaevel PEbrahimian TSuhard DPhan GDublineau ITack KBenderitter M, et al.Effects of repeated potassium iodide administration on genes involved in synthesis and secretion of thyroid hormone in adult male rat. Molecular and Cellular Endocrinology2018474119\u2013126. (https:\/\/doi.org\/10.1016\/j.mce.2018.02.017)"},{"key":"bib21","series-title":"Journal of Nutritional Science and Vitaminology","first-page":"447","article-title":"Serum and tissue iodine concentrations in rats fed diets supplemented with kombu powder or potassium iodide","volume":"60","author":"Yoshida","year":"2014","unstructured":"Yoshida MMukama AHosomi RFukunaga K & Nishiyama T. Serum and tissue iodine concentrations in rats fed diets supplemented with kombu powder or potassium iodide. Journal of Nutritional Science and Vitaminology201460447\u2013449. (https:\/\/doi.org\/10.3177\/jnsv.60.447)"},{"key":"bib22","series-title":"Thyroid","first-page":"1488","article-title":"Underlying mechanisms of pituitary-thyroid axis function disruption by chronic iodine excess in rats","volume":"26","author":"Calil-Silveira","year":"2016","unstructured":"Calil-Silveira JSerrano-Nascimento CLaconca RCSchmiedecke LSalgueiro RBKondo AK & Nunes MT. Underlying mechanisms of pituitary-thyroid axis function disruption by chronic iodine excess in rats. Thyroid2016261488\u20131498. (https:\/\/doi.org\/10.1089\/thy.2015.0338)"},{"key":"bib23","series-title":"Biochemistry and Biophysics Reports","first-page":"100816","article-title":"Effect of repetitive potassium iodide on thyroid and cardiovascular functions in elderly rats","volume":"24","author":"Lebsir","year":"2020","unstructured":"Lebsir DCantabella ECohen DSache AEbrahimian TKereselidze DAmine Benadjaoud MMaurisier FCGuigon PRen\u00e9 Jourdain J, et al.Effect of repetitive potassium iodide on thyroid and cardiovascular functions in elderly rats. Biochemistry and Biophysics Reports202024100816. (https:\/\/doi.org\/10.1016\/j.bbrep.2020.100816)"},{"key":"bib24","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"212","article-title":"Thyroid hormone synthesis and secretion in humans after 80 milligrams of iodine for 15 days and subsequent withdrawal","volume":"92","author":"Theodoropoulou","year":"2007","unstructured":"Theodoropoulou AVagenakis AGMakri M & Markou KB. Thyroid hormone synthesis and secretion in humans after 80 milligrams of iodine for 15 days and subsequent withdrawal. Journal of Clinical Endocrinology and Metabolism200792212\u2013214. (https:\/\/doi.org\/10.1210\/jc.2006-1189)"},{"key":"bib25","series-title":"American Journal of Physiology","first-page":"C893","article-title":"Posttranscriptional regulation of sodium-iodide symporter mRNA expression in the rat thyroid gland by acute iodide administration","volume":"298","author":"Serrano-Nascimento","year":"2010","unstructured":"Serrano-Nascimento CCalil-Silveira J & Nunes MT. Posttranscriptional regulation of sodium-iodide symporter mRNA expression in the rat thyroid gland by acute iodide administration. American Journal of Physiology2010298C893\u2013C899. (https:\/\/doi.org\/10.1152\/ajpcell.00224.2009)"},{"key":"bib26","series-title":"Journal of Endocrinology","first-page":"89","article-title":"Inhibition of intrathyroidal dehalogenation by iodide","volume":"208","author":"Solis-S","year":"2011","unstructured":"Solis-S JCVillalobos POrozco ADelgado GQuintanar-Stephano AGarcia-Solis PHernandez-Montiel HLRobles-Osorio L & Valverde-R C. Inhibition of intrathyroidal dehalogenation by iodide. Journal of Endocrinology201120889\u201396. (https:\/\/doi.org\/10.1677\/JOE-10-0300)"},{"key":"bib27","series-title":"Thyroid","first-page":"344","article-title":"Potassium iodide prophylaxis: what have we learned and questions raised by the accident at the Fukushima Daiichi Nuclear Power Plant","volume":"22","author":"Schneider","year":"2012","unstructured":"Schneider AB & Smith JM. Potassium iodide prophylaxis: what have we learned and questions raised by the accident at the Fukushima Daiichi Nuclear Power Plant. Thyroid201222344\u2013346. (https:\/\/doi.org\/10.1089\/thy.2012.2204.com)"},{"key":"bib28","series-title":"Endocrinology","first-page":"1540","article-title":"Excess iodide induces an acute inhibition of the sodium\/iodide symporter in thyroid male rat cells by increasing reactive oxygen species","volume":"156","author":"Arriagada","year":"2015","unstructured":"Arriagada AAAlbornoz EOpazo MCBecerra AVidal GFardella CMichea LCarrasco NSimon FElorza AA, et al.Excess iodide induces an acute inhibition of the sodium\/iodide symporter in thyroid male rat cells by increasing reactive oxygen species. Endocrinology20151561540\u20131551. (https:\/\/doi.org\/10.1210\/en.2014-1371)"},{"key":"bib29","series-title":"Biological Trace Element Research","first-page":"193","article-title":"The effect on sodium\/iodide symporter and pendrin in thyroid colloid retention developed by excess iodide intake","volume":"172","author":"Chen","year":"2016","unstructured":"Chen XYLin CHYang LHLi WGZhang JWZheng WWWang XQian JHuang JL & Lei YX. The effect on sodium\/iodide symporter and pendrin in thyroid colloid retention developed by excess iodide intake. Biological Trace Element Research2016172193\u2013200. (https:\/\/doi.org\/10.1007\/s12011-015-0580-4)"},{"key":"bib30","series-title":"Biological Trace Element Research","first-page":"377","article-title":"Effect of prolonged iodine overdose on Type 2 iodothyronine deiodinase ubiquitination-related enzymes in the rat pituitary","volume":"174","author":"Zhang","year":"2016","unstructured":"Zhang XJiang YHan WLiu AXie XHan CFan CWang HZhang HDing S, et al.Effect of prolonged iodine overdose on Type 2 iodothyronine deiodinase ubiquitination-related enzymes in the rat pituitary. Biological Trace Element Research2016174377\u2013386. (https:\/\/doi.org\/10.1007\/s12011-016-0723-2)"},{"key":"bib31","series-title":"American Journal of Physiology-Cell Physiology","first-page":"C576","article-title":"Iodide excess regulates its own efflux: a possible involvement of pendrin","volume":"310","author":"Calil-Silveira","year":"2016","unstructured":"Calil-Silveira JSerrano-Nascimento CKopp PA & Nunes MT. Iodide excess regulates its own efflux: a possible involvement of pendrin. American Journal of Physiology-Cell Physiology2016310C576\u2013C582. (https:\/\/doi.org\/10.1152\/ajpcell.00210.2015)"},{"key":"bib32","series-title":"Thyroid","first-page":"203","article-title":"Functional characterization of human thyroid tissue with immunohistochemistry","volume":"17","author":"Faggiano","year":"2007","unstructured":"Faggiano ACaillou BLacroix LTalbot MFiletti SBidart JM & Schlumberger M. Functional characterization of human thyroid tissue with immunohistochemistry. Thyroid200717203\u2013211. (https:\/\/doi.org\/10.1089\/thy.2006.0174)"},{"key":"bib33","series-title":"Journal of Pharmaceutical Research","first-page":"1","article-title":"Toxicology of repeated iodine thyroid blocking in adult rat","volume":"3","author":"Lebsir","year":"2018","unstructured":"Lebsir DCohen DManens LGrison STack KBenderitter MPech Alestaevel P & Souidi M. Toxicology of repeated iodine thyroid blocking in adult rat. Journal of Pharmaceutical Research201831\u20138."},{"key":"bib34","series-title":"Journal of Endocrinology","first-page":"R13","article-title":"Empowering thyroid hormone research in human subjects using OMICs technologies","volume":"238","author":"Pietzner","year":"2018","unstructured":"Pietzner MKacprowski T & Friedrich N. Empowering thyroid hormone research in human subjects using OMICs technologies. Journal of Endocrinology2018238R13\u2013R29. (https:\/\/doi.org\/10.1530\/JOE-18-0117)"},{"key":"bib35","series-title":"Genomics","first-page":"356","article-title":"Differential gene expression analysis of iodide-treated rat thyroid follicular cell line PCCl3","volume":"91","author":"Leoni","year":"2008","unstructured":"Leoni SGGalante PARicarte-Filho JC & Kimura ET. Differential gene expression analysis of iodide-treated rat thyroid follicular cell line PCCl3. Genomics200891356\u2013366. (https:\/\/doi.org\/10.1016\/j.ygeno.2007.12.009)"},{"key":"bib36","series-title":"Archives of Toxicology","first-page":"803","article-title":"Metabolomics evaluation of repeated administration of potassium iodide on adult male rats","volume":"94","author":"Rosique","year":"2020","unstructured":"Rosique CLebsir DBenatia SGuigon PCaire-Maurisier FBenderitter MSouidi M & Martin JC. Metabolomics evaluation of repeated administration of potassium iodide on adult male rats. Archives of Toxicology202094803\u2013812. (https:\/\/doi.org\/10.1007\/s00204-020-02666-w)"},{"key":"bib37","series-title":"Molecular Biosystems","first-page":"385","article-title":"Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis","volume":"7","author":"Wurtz","year":"2011","unstructured":"Wurtz PSoininen PKangas AJMakinen VPGroop PHSavolainen MJJuonala MViikari JSKahonen MLehtimaki T, et al.Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis. Molecular Biosystems20117385\u2013393. (https:\/\/doi.org\/10.1039\/c0mb00066c)"},{"key":"bib38","series-title":"Journal of Dairy Science","first-page":"5531","article-title":"Metabotypes with elevated protein and lipid catabolism and inflammation precede clinical mastitis in prepartal transition dairy cows","volume":"101","author":"Zandkarimi","year":"2018","unstructured":"Zandkarimi FVanegas JFern XMaier CS & Bobe G. Metabotypes with elevated protein and lipid catabolism and inflammation precede clinical mastitis in prepartal transition dairy cows. Journal of Dairy Science20181015531\u20135548. (https:\/\/doi.org\/10.3168\/jds.2017-13977)"},{"key":"bib39","series-title":"Handbook of Life Stress, Cognition and Health","first-page":"629","article-title":"Allostasis: a new paradigm to explain arousal pathology","author":"Sterling","year":"1988","unstructured":"Sterling P & Eyer J. Allostasis: a new paradigm to explain arousal pathology. In Handbook of Life Stress, Cognition and Health, pp. 629\u2013649. Fisher S & Reason J, Eds. New York: Wiley & Sons1988."},{"key":"bib40","series-title":"Cell Metabolism","first-page":"361","article-title":"Physiological regulation: how it really works","volume":"24","author":"Ramsay","year":"2016","unstructured":"Ramsay DS & Woods SC. Physiological regulation: how it really works. Cell Metabolism201624361\u2013364. (https:\/\/doi.org\/10.1016\/j.cmet.2016.08.004)"},{"key":"bib41","series-title":"Best Practice and Research. Clinical Endocrinology and Metabolism","first-page":"107","article-title":"Iodine excess","volume":"24","author":"B\u00fcrgi","year":"2010","unstructured":"B\u00fcrgi H. Iodine excess. Best Practice and Research. Clinical Endocrinology and Metabolism201024107\u2013115. (https:\/\/doi.org\/10.1016\/j.beem.2009.08.010)"},{"key":"bib42","series-title":"Journal of Biological Chemistry","first-page":"555","article-title":"Plasma inorganic iodide as a homeostatic regulator of thyroid function","volume":"174","author":"Wolff","year":"1948","unstructured":"Wolff J & Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. Journal of Biological Chemistry1948174555\u2013564. (https:\/\/doi.org\/10.1016\/S0021-9258(1857335-X)"},{"key":"bib43","series-title":"Nature Reviews. Endocrinology","first-page":"136","article-title":"Consequences of excess iodine","volume":"10","author":"Leung","year":"2014","unstructured":"Leung AM & Braverman LE. Consequences of excess iodine. Nature Reviews. Endocrinology201410136\u2013142. (https:\/\/doi.org\/10.1038\/nrendo.2013.251)"},{"key":"bib44","series-title":"Biochimie","first-page":"208","article-title":"A systems biology approach to propose a new mechanism of regulation of repetitive prophylaxis of stable iodide on sodium\/iodide symporter (NIS)","volume":"162","author":"Cohen","year":"2019","unstructured":"Cohen DPALebsir DBenderitter M & Souidi M. A systems biology approach to propose a new mechanism of regulation of repetitive prophylaxis of stable iodide on sodium\/iodide symporter (NIS). Biochimie2019162208\u2013215. (https:\/\/doi.org\/10.1016\/j.biochi.2019.04.024)"},{"key":"bib45","series-title":"Agency EM, Editor","first-page":"10","article-title":"Guideline on Repeated Dose Toxicity (CPMP\/SWP\/1042\/99 Rev.1 corr.) ; EMEA Note for guidance on Toxicokinetics: A guidance for Assessing Systemic Exposure in Toxicology Studies (CPMP\/ICH\/384\/95, ICH S3A)","year":"1995","unstructured":"OECD Guidelines 407, 409 and 474. Guideline on Repeated Dose Toxicity (CPMP\/SWP\/1042\/99 Rev.1 corr.) ; EMEA Note for guidance on Toxicokinetics: A guidance for Assessing Systemic Exposure in Toxicology Studies (CPMP\/ICH\/384\/95, ICH S3A). In Agency EM, Editor. CPMP\/ICH\/384\/95 p. 10: London: EMEA1995."},{"key":"bib46","series-title":"Environmental Advances","first-page":"100293","article-title":"Potassium iodide (KI) prophylaxis in the case of a nuclear accident: a new marketing authorization in France","volume":"9","author":"Benderitter","year":"2022","unstructured":"Benderitter MCaire-Maurisier FCrambes CPourcher TMartin J-CDarcourt J & Souidi M. Potassium iodide (KI) prophylaxis in the case of a nuclear accident: a new marketing authorization in France. Environmental Advances20229100293. (https:\/\/doi.org\/10.1016\/j.envadv.2022.100293)"},{"key":"bib47","series-title":"Test, Bacterial Reverse Mutation","article-title":"Guideline for testing of chemicals","year":"2020","unstructured":"471 OG. Guideline for testing of chemicals. Test, Bacterial Reverse Mutation2020."},{"key":"bib48","series-title":"2016 and ICH S2 (R1) Guideline on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use (EMA\/CHMP\/ICH\/126642\/2008)","article-title":"Test No. 487: In Vitro Mammalian Cell Micronucleus Test","unstructured":"487 Og. Test No. 487: In Vitro Mammalian Cell Micronucleus Test. 2016 and ICH S2 (R1) Guideline on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use (EMA\/CHMP\/ICH\/126642\/2008)."},{"key":"bib49","series-title":"Clinical Pharmacology and Therapeutics","first-page":"210","article-title":"Preclinical predictors of clinical safety: opportunities for improvement","volume":"82","author":"Sistare","year":"2007","unstructured":"Sistare FD & DeGeorge JJ. Preclinical predictors of clinical safety: opportunities for improvement. Clinical Pharmacology and Therapeutics200782210\u2013214. (https:\/\/doi.org\/10.1038\/sj.clpt.6100243)"},{"key":"bib50","series-title":"Current Protocols in Pharmacology","first-page":"10.10.1","article-title":"Primary observation (Irwin) test in rodents for assessing acute toxicity of a test agent and its effects on behavior and physiological function","volume":"27","author":"Roux","year":"2004","unstructured":"Roux SSabl\u00e9 E & Porsolt RD. Primary observation (Irwin) test in rodents for assessing acute toxicity of a test agent and its effects on behavior and physiological function. Current Protocols in Pharmacology20042710.10.1\u201310.10.23. (https:\/\/doi.org\/10.1002\/0471141755.ph1010s27)"},{"key":"bib51","article-title":"ICH guid","year":"2013","unstructured":"M3(R2) Ig. ICH guideline M3(R2) on non-clinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals. In EMA, Ed. London2013."},{"key":"bib52","series-title":"FaDA, Center for Drug Evaluation and Research (CDER). Guidance for industry estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers","year":"2005","unstructured":"U.S. Department of Health and Human Services. FaDA, Center for Drug Evaluation and Research (CDER). Guidance for industry estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Rockville, MD: FDA2005."},{"key":"bib53","series-title":"FASEB Journal","first-page":"659","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw SNihal M & Ahmad N. Dose translation from animal to human studies revisited. FASEB Journal200822659\u2013661. (https:\/\/doi.org\/10.1096\/fj.07-9574LSF)"}],"container-title":["European Thyroid Journal"],"original-title":[],"link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/13\/1\/ETJ-23-0139.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/13\/1\/ETJ-23-0139.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/13\/1\/ETJ-23-0139.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:51:51Z","timestamp":1784555511000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/etj\/article\/2964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":53,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1530\/etj-23-0139","relation":{},"ISSN":["2235-0802"],"issn-type":[{"value":"2235-0802","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]}}}